Listed

Viridian Therapeutics, Inc.\DE

VRDNNasdaqCIK 1590750HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$284.0k, Q2 FY2026
Operating income−$126.3m, Q2 FY2026
Net income−$127.1m, Q2 FY2026
Viridian Therapeutics, Inc.\DE, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.1Revenue, Q3 FY2023, three months to 2023-09-30$72.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-11-12, accession 0001590750-24-000023.Report this figure0.1Revenue, Q4 FY2023, three months to 2023-12-31$72.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-26, accession 0001590750-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure0.1Revenue, Q1 FY2024, three months to 2024-03-31$72.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-05-06, accession 0001590750-25-000008.Report this figure0.1Revenue, Q2 FY2024, three months to 2024-06-30$72.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-08-06, accession 0001590750-25-000012.Report this figure0.1Revenue, Q3 FY2024, three months to 2024-09-30$86.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure0.1Revenue, Q4 FY2024, three months to 2024-12-31$72.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-26, accession 0001590750-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure0.1Revenue, Q1 FY2025, three months to 2025-03-31$72.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-05, accession 0001590750-26-000012.Report this figure0.1Revenue, Q2 FY2025, three months to 2025-06-30$75.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure70.6Revenue, Q3 FY2025, three months to 2025-09-30$70.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure0.1Revenue, Q4 FY2025, three months to 2025-12-31$132.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-26, accession 0001590750-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure0.1Revenue, Q1 FY2026, three months to 2026-03-31$141.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-05, accession 0001590750-26-000012.Report this figure0.3Revenue, Q2 FY2026, three months to 2026-06-30$284.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Selling, general and administrative$mnot reportednot reportednot reportednot reportednot reportednot reported17.1Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$17.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-05, accession 0001590750-26-000012.Report this figure20.2Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$20.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figurenot reportednot reported38.7Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$38.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-05, accession 0001590750-26-000012.Report this figure55.0Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$55.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure
Operating income$m(51.2)Operating income, Q3 FY2023, three months to 2023-09-30−$51.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001590750-24-000023.Report this figure(71.5)Operating income, Q4 FY2023, three months to 2023-12-31−$71.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001590750-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(55.9)Operating income, Q1 FY2024, three months to 2024-03-31−$55.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0001590750-25-000008.Report this figure(72.2)Operating income, Q2 FY2024, three months to 2024-06-30−$72.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001590750-25-000012.Report this figure(83.5)Operating income, Q3 FY2024, three months to 2024-09-30−$83.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure(87.5)Operating income, Q4 FY2024, three months to 2024-12-31−$87.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001590750-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(93.9)Operating income, Q1 FY2025, three months to 2025-03-31−$93.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001590750-26-000012.Report this figure(107)Operating income, Q2 FY2025, three months to 2025-06-30−$106.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure(40.0)Operating income, Q3 FY2025, three months to 2025-09-30−$40.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure(123)Operating income, Q4 FY2025, three months to 2025-12-31−$122.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001590750-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(116)Operating income, Q1 FY2026, three months to 2026-03-31−$116.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001590750-26-000012.Report this figure(126)Operating income, Q2 FY2026, three months to 2026-06-30−$126.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure
Interest expense$m0.6Interest expense, Q3 FY2023, three months to 2023-09-30$600.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-12, accession 0001590750-24-000023.Report this figure0.4Interest expense, Q4 FY2023, three months to 2023-12-31$400.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001590750-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure0.6Interest expense, Q1 FY2024, three months to 2024-03-31$587.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-06, accession 0001590750-25-000008.Report this figure0.6Interest expense, Q2 FY2024, three months to 2024-06-30$597.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-06, accession 0001590750-25-000012.Report this figure0.5Interest expense, Q3 FY2024, three months to 2024-09-30$529.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure0.5Interest expense, Q4 FY2024, three months to 2024-12-31$517.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001590750-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure0.6Interest expense, Q1 FY2025, three months to 2025-03-31$550.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-05, accession 0001590750-26-000012.Report this figure0.5Interest expense, Q2 FY2025, three months to 2025-06-30$514.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure0.6Interest expense, Q3 FY2025, three months to 2025-09-30$560.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure3.3Interest expense, Q4 FY2025, three months to 2025-12-31$3.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001590750-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure3.5Interest expense, Q1 FY2026, three months to 2026-03-31$3.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-05, accession 0001590750-26-000012.Report this figure8.3Interest expense, Q2 FY2026, three months to 2026-06-30$8.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure
Net income$m(47.7)Net income, Q3 FY2023, three months to 2023-09-30−$47.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001590750-24-000023.Report this figure(66.9)Net income, Q4 FY2023, three months to 2023-12-31−$66.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001590750-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(48.5)Net income, Q1 FY2024, three months to 2024-03-31−$48.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure(65.0)Net income, Q2 FY2024, three months to 2024-06-30−$65.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure(76.7)Net income, Q3 FY2024, three months to 2024-09-30−$76.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure(79.7)Net income, Q4 FY2024, three months to 2024-12-31−$79.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001590750-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(86.9)Net income, Q1 FY2025, three months to 2025-03-31−$86.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure(101)Net income, Q2 FY2025, three months to 2025-06-30−$100.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure(34.6)Net income, Q3 FY2025, three months to 2025-09-30−$34.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure(120)Net income, Q4 FY2025, three months to 2025-12-31−$120.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001590750-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(105)Net income, Q1 FY2026, three months to 2026-03-31−$104.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure(127)Net income, Q2 FY2026, three months to 2026-06-30−$127.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure
Diluted EPS$ per share(1.09)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001590750-24-000023.Report this figurenot reported(0.79)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.79 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-05-08, accession 0001590750-24-000012.Report this figure(1.02)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-08-08, accession 0001590750-24-000019.Report this figure(1.15)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001590750-24-000023.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported
Basic EPS$ per share(1.09)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001590750-24-000023.Report this figurenot reported(0.79)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.79 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-05-08, accession 0001590750-24-000012.Report this figure(1.02)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-08-08, accession 0001590750-24-000019.Report this figure(1.15)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001590750-24-000023.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported

Balance sheet

Long-term debt$20.9m, Q3 FY2025
Shareholders' equity$662.1m, Q2 FY2026
Viridian Therapeutics, Inc.\DE, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current assets$m324Current assets, Q3 FY2023, at 2023-09-30$323.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001590750-23-000013.Report this figure486Current assets, FY2023, at 2023-12-31$486.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-03, accession 0001590750-25-000004.Report this figure627Current assets, Q1 FY2024, at 2024-03-31$626.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0001590750-24-000012.Report this figure582Current assets, Q2 FY2024, at 2024-06-30$581.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001590750-24-000019.Report this figure767Current assets, Q3 FY2024, at 2024-09-30$767.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001590750-24-000023.Report this figure738Current assets, FY2024, at 2024-12-31$738.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001590750-26-000007.Report this figure657Current assets, Q1 FY2025, at 2025-03-31$657.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0001590750-25-000008.Report this figure579Current assets, Q2 FY2025, at 2025-06-30$578.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001590750-25-000012.Report this figure572Current assets, Q3 FY2025, at 2025-09-30$571.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure894Current assets, FY2025, at 2025-12-31$894.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure785Current assets, Q1 FY2026, at 2026-03-31$784.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0001590750-26-000012.Report this figure1,081Current assets, Q2 FY2026, at 2026-06-30$1.08bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure
Total assets$m329Total assets, Q3 FY2023, at 2023-09-30$328.8m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001590750-23-000013.Report this figure490Total assets, FY2023, at 2023-12-31$490.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-03, accession 0001590750-25-000004.Report this figure630Total assets, Q1 FY2024, at 2024-03-31$630.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001590750-24-000012.Report this figure586Total assets, Q2 FY2024, at 2024-06-30$585.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001590750-24-000019.Report this figure772Total assets, Q3 FY2024, at 2024-09-30$771.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001590750-24-000023.Report this figure742Total assets, FY2024, at 2024-12-31$742.4m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001590750-26-000007.Report this figure661Total assets, Q1 FY2025, at 2025-03-31$661.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0001590750-25-000008.Report this figure582Total assets, Q2 FY2025, at 2025-06-30$582.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001590750-25-000012.Report this figure577Total assets, Q3 FY2025, at 2025-09-30$577.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure899Total assets, FY2025, at 2025-12-31$899.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure789Total assets, Q1 FY2026, at 2026-03-31$789.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0001590750-26-000012.Report this figure1,097Total assets, Q2 FY2026, at 2026-06-30$1.10bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure
Current liabilities$m23.2Current liabilities, Q3 FY2023, at 2023-09-30$23.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001590750-23-000013.Report this figure26.6Current liabilities, FY2023, at 2023-12-31$26.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-03, accession 0001590750-25-000004.Report this figure26.1Current liabilities, Q1 FY2024, at 2024-03-31$26.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0001590750-24-000012.Report this figure36.8Current liabilities, Q2 FY2024, at 2024-06-30$36.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001590750-24-000019.Report this figure41.4Current liabilities, Q3 FY2024, at 2024-09-30$41.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001590750-24-000023.Report this figure47.9Current liabilities, FY2024, at 2024-12-31$47.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001590750-26-000007.Report this figure33.7Current liabilities, Q1 FY2025, at 2025-03-31$33.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0001590750-25-000008.Report this figure52.6Current liabilities, Q2 FY2025, at 2025-06-30$52.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001590750-25-000012.Report this figure50.7Current liabilities, Q3 FY2025, at 2025-09-30$50.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure70.7Current liabilities, FY2025, at 2025-12-31$70.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure51.8Current liabilities, Q1 FY2026, at 2026-03-31$51.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0001590750-26-000012.Report this figure63.8Current liabilities, Q2 FY2026, at 2026-06-30$63.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure
Total liabilities$m45.2Total liabilities, Q3 FY2023, at 2023-09-30$45.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001590750-23-000013.Report this figure48.4Total liabilities, FY2023, at 2023-12-31$48.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-03, accession 0001590750-25-000004.Report this figure47.9Total liabilities, Q1 FY2024, at 2024-03-31$47.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0001590750-24-000012.Report this figure56.3Total liabilities, Q2 FY2024, at 2024-06-30$56.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001590750-24-000019.Report this figure64.4Total liabilities, Q3 FY2024, at 2024-09-30$64.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001590750-24-000023.Report this figure70.8Total liabilities, FY2024, at 2024-12-31$70.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001590750-26-000007.Report this figure56.5Total liabilities, Q1 FY2025, at 2025-03-31$56.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0001590750-25-000008.Report this figure67.2Total liabilities, Q2 FY2025, at 2025-06-30$67.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0001590750-25-000012.Report this figure74.2Total liabilities, Q3 FY2025, at 2025-09-30$74.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure177Total liabilities, FY2025, at 2025-12-31$177.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure153Total liabilities, Q1 FY2026, at 2026-03-31$153.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-05, accession 0001590750-26-000012.Report this figure435Total liabilities, Q2 FY2026, at 2026-06-30$435.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure
Long-term debt$m20.0Long-term debt, Q3 FY2023, at 2023-09-30$20.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-13, accession 0001590750-23-000013.Report this figure20.2Long-term debt, FY2023, at 2023-12-31$20.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-03, accession 0001590750-25-000004.Report this figure20.3Long-term debt, Q1 FY2024, at 2024-03-31$20.3m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-08, accession 0001590750-24-000012.Report this figure17.5Long-term debt, Q2 FY2024, at 2024-06-30$17.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-08, accession 0001590750-24-000019.Report this figure20.5Long-term debt, Q3 FY2024, at 2024-09-30$20.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-12, accession 0001590750-24-000023.Report this figure20.6Long-term debt, FY2024, at 2024-12-31$20.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure20.7Long-term debt, Q1 FY2025, at 2025-03-31$20.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-06, accession 0001590750-25-000008.Report this figure12.4Long-term debt, Q2 FY2025, at 2025-06-30$12.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-06, accession 0001590750-25-000012.Report this figure20.9Long-term debt, Q3 FY2025, at 2025-09-30$20.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figurenot reportednot reportednot reported
Current portion of debt$mnot reported0.0Current portion of debt, FY2023, at 2023-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-08, accession 0001590750-24-000019.Report this figurenot reported3.0Current portion of debt, Q2 FY2024, at 2024-06-30$3.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-08, accession 0001590750-24-000019.Report this figurenot reported0.0Current portion of debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-06, accession 0001590750-25-000012.Report this figurenot reported8.4Current portion of debt, Q2 FY2025, at 2025-06-30$8.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-06, accession 0001590750-25-000012.Report this figurenot reportednot reportednot reportednot reported
Shareholders' equity$m284Shareholders' equity, Q3 FY2023, at 2023-09-30$283.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001590750-24-000023.Report this figure442Shareholders' equity, FY2023, at 2023-12-31$442.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001590750-26-000007.Report this figure583Shareholders' equity, Q1 FY2024, at 2024-03-31$582.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure529Shareholders' equity, Q2 FY2024, at 2024-06-30$529.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure707Shareholders' equity, Q3 FY2024, at 2024-09-30$707.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure672Shareholders' equity, FY2024, at 2024-12-31$671.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure604Shareholders' equity, Q1 FY2025, at 2025-03-31$604.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure515Shareholders' equity, Q2 FY2025, at 2025-06-30$515.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure503Shareholders' equity, Q3 FY2025, at 2025-09-30$503.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure722Shareholders' equity, FY2025, at 2025-12-31$722.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure636Shareholders' equity, Q1 FY2026, at 2026-03-31$636.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure662Shareholders' equity, Q2 FY2026, at 2026-06-30$662.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure

Cash flow

Operating cash flow−$105.3m, Q2 FY2026
Capital expenditure$1.3m, Q2 FY2026
Viridian Therapeutics, Inc.\DE, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(39.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$39.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001590750-24-000023. Derived: 9-month figure less the 6-month figure.Report this figure(38.0)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$38.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001590750-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(45.2)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$45.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0001590750-25-000008.Report this figure(46.1)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$46.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001590750-25-000012. Derived: 6-month figure less the 3-month figure.Report this figure(67.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$67.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001590750-25-000020. Derived: 9-month figure less the 6-month figure.Report this figure(73.3)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$73.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001590750-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(92.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$92.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001590750-26-000012.Report this figure(75.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$75.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001590750-26-000018. Derived: 6-month figure less the 3-month figure.Report this figure(84.6)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$84.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001590750-25-000020. Derived: 9-month figure less the 6-month figure.Report this figure(23.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$23.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001590750-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(120)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$119.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001590750-26-000012.Report this figure(105)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$105.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001590750-26-000018. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.4Capital expenditure, Q3 FY2023, three months to 2023-09-30$404.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001590750-24-000023. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$48.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001590750-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0001590750-25-000008.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$104.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0001590750-25-000012. Derived: 6-month figure less the 3-month figure.Report this figure0.3Capital expenditure, Q3 FY2024, three months to 2024-09-30$293.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001590750-25-000020. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$114.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001590750-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$86.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001590750-26-000012.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$42.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001590750-26-000018. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$127.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001590750-25-000020. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$240.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001590750-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$23.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001590750-26-000012.Report this figure1.3Capital expenditure, Q2 FY2026, three months to 2026-06-30$1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001590750-26-000018. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)81.59m, Q2 FY2025
Viridian Therapeutics, Inc.\DE, shares, quarterly
Line itemUnitQ3 FY20212021-09-30Q1 FY20222022-03-31Q2 FY20222022-06-30Q3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30
Diluted shares (weighted)m shares11.2Diluted shares (weighted), Q3 FY2021, three months to 2021-09-3011,183,578 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-11-14, accession 0001590750-22-000012.Report this figure26.1Diluted shares (weighted), Q1 FY2022, three months to 2022-03-3126,126,092 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-05-10, accession 0001590750-23-000003.Report this figure27.8Diluted shares (weighted), Q2 FY2022, three months to 2022-06-3027,762,257 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-08-08, accession 0001590750-23-000008.Report this figure33.7Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3033,742,076 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001590750-23-000013.Report this figure42.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3142,242,309 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0001590750-24-000012.Report this figure43.3Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3043,253,457 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001590750-24-000019.Report this figure43.7Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3043,654,577 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001590750-24-000023.Report this figure61.1Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3161,099,038 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0001590750-25-000008.Report this figure63.9Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3063,854,514 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001590750-25-000012.Report this figure66.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3066,420,063 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001590750-25-000020.Report this figure81.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3181,344,134 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001590750-26-000012.Report this figure81.6Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3081,593,463 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure

Shares outstanding: 113.29mShares outstanding, period not labelled, at 2026-08-03113,292,269 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001590750-26-000018.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. Listed shows no prices and gives no investment advice.